articleJournal of the American College of CardiologyApr 2, 2025Closed access

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia

MKMichael KorenRBRick B. VegaNANikhil AgrawalYXYuejia XuABApril Barbour

Jacksonville University · AstraZeneca (Poland) · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

48
total citations
FWCI
76.19
Percentile
100%
References
29
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Medicine
  • Ezetimibe
  • PCSK9
  • Tolerability
  • Placebo
  • Internal medicine
  • Clinical endpoint
  • Familial hypercholesterolemia
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding